veonetinib   Click here for help

GtoPdb Ligand ID: 13493

Synonyms: Example 3 [WO2010021918]
Compound class: Synthetic organic
Comment: Veonetinib is the INN for a tyrosine kinase inhibitor from WHO proposed INN list 131 (August 2024). This is a racemic mixture of optical isomers. We show the structure without stereo-specificity to represent the racemate. The structure for veonetinib is claimed as Example 3 in patent WO2010021918 (Advenchen Laboratories) [1]. There is no information in this patent regarding the specific kinase(s) inhibited (just experimental evidence of antiproliferative activity against lung and colon cancer cell lines).
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 75.55
Molecular weight 477.53
XLogP 1.82
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=CC2=C(C(=CC=C2N1)OC3=CC=NC4=C3C=C(C(=C4)OCCN5CC(C6(CC6)C5)O)OC)F
Isomeric SMILES CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCCN5CC(C6(C5)CC6)O)OC
InChI InChI=1S/C27H28FN3O4/c1-16-11-18-19(30-16)3-4-22(26(18)28)35-21-5-8-29-20-13-24(23(33-2)12-17(20)21)34-10-9-31-14-25(32)27(15-31)6-7-27/h3-5,8,11-13,25,30,32H,6-7,9-10,14-15H2,1-2H3
InChI Key RYPUFHJIOUAMKT-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Chen GPC. (2010)
Compounds as kinase inhibitors.
Patent number: WO2010021918A1. Assignee: Advenchen Laboratories, Llc. Priority date: 13/08/2009. Publication date: 25/02/2010.